Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Semaglutide GLP-1, the key ingredient in Wegovy, has been shown to help with significant weight loss by regulating appetite and blood sugar levels
In addition, in October 2024, AstraZeneca announced that it will discontinue marketing brand Byetta
This protocol isn't appropriate for patients who are pregnant or nursing, individuals under 18, those with active cancer, or patients with contraindications to GLP-1 medications (medullary thyroid carcinoma history, MEN2 syndrome, history of pancreatitis)
When medications are exposed to temperature excursions, their safety and efficacy cannot be assured
This description is limited to receptor and pathway behavior measured in experimental models
